Design And Rationale Of A Phase 3 Study To Evaluate The Efficacy And Safety Of Nucresiran (aln-ttrsc04) In Patients With Transthyretin Amyloidosis With Cardiomyopathy

Journal of Cardiac Failure 2026

View at publisher

Authors: M Fontana, Ahmad Masri, Mathew S. Maurer, John J.V. McMurray, Scott David Solomon, Minzhao Liu, Patrick Y. Jay, Ronald M. Witteles

DOI: 10.1016/j.cardfail.2025.11.044

Cited by: 0

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Alzheimer's disease research and treatments Amyotrophic Lateral Sclerosis Research